Abstract
More than two-thirds of all known G-protein coupled receptors are known to modulate the function of adenylate cyclase resulting in altered levels of cAMP. In turn, cAMP fluctuations transform agonist binding events into physiological changes in cell behavior. The advent of nonradioactive, homogeneous methods of measuring intracellular cAMP has enabled the rapid growth of drug discovery and research applications for these GPCR targets. In this chapter, we describe a nonradioactive, chemiluminescent cAMP detection method using enzyme fragment complementation technology to detect a wide range of GPCR modulators which is also suitable for high-throughput screening.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Milligan G, Kostenis E (2006) Heterotrimeric G-proteins: a short history. Br J Pharmacol 147(Suppl 1):S46–S55
Insel PA, Zhang L, Murray F, Yokouchi H, Zambon AC (2011) Cyclic AMP is both a pro-apoptotic and anti-apoptotic second messenger. Acta Physiol (Oxf). doi:10.1111/j.1748-1716.2011.02273.x
Kvajo M, McKellar H, Gogos JA (2010) Molecules, signaling, and schizophrenia. Curr Top Behav Neurosci 4:629–656
Madsen L, Kristiansen K (2010) The importance of dietary modulation of cAMP and insulin signaling in adipose tissue and the development of obesity. Ann N Y Acad Sci 1190:1–14
Hill SJ, Williams C, May LT (2010) Insights into GPCR pharmacology from the measurement of changes in intracellular cyclic AMP; advantages and pitfalls of differing methodologies. Br J Pharmacol 161:1266–1275
Bradley J, McLoughlin D (2009) Use of the DiscoveRx Hit hunter cAMPII assay for direct measurement of cAMP in Gs and Gi GPCRs. Methods Mol Biol 552:171–179
Weber M, Ferrer M, Zheng W, Inglese J, Strulovici B, Kunapuli P (2004) A 1536-well cAMP assay for Gs- and Gi-coupled receptors using enzyme fragmentation complementation. Assay Drug Dev Technol 2:39–49
Khanna PL, Dworschack RT, Manning WB, Harris JD (1989) A new homogeneous enzyme immunoassay using recombinant enzyme fragments. Clin Chim Acta 185:231–239
Engel WD, Khanna PL (1992) CEDIA in vitro diagnostics with a novel homogeneous immunoassay technique. Current status and future prospects. J Immunol Methods 150:99–102
Yao BB, Mukherjee S, Fan Y, Garrison TR, Daza AV, Grayson GK, Hooker BA, Dart MJ, Sullivan JP, Meyer MD (2006) In vitro pharmacological characterization of AM1241: a protean agonist at the cannabinoid CB2 receptor? Br J Pharmacol 149:145–154
Golla R, Seethala R (2002) A homogeneous enzyme fragment complementation cyclic AMP screen for GPCR agonists. J Biomol Screen 7:515–525
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Bassoni, D.L., Jafri, Q., Sastry, S., Mathrubutham, M., Wehrman, T.S. (2012). Characterization of G-Protein Coupled Receptor Modulators Using Homogeneous cAMP Assays. In: Davenport, A. (eds) Receptor Binding Techniques. Methods in Molecular Biology, vol 897. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-909-9_8
Download citation
DOI: https://doi.org/10.1007/978-1-61779-909-9_8
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61779-908-2
Online ISBN: 978-1-61779-909-9
eBook Packages: Springer Protocols